Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · IEX Real-Time Price · USD
4.730
-0.250 (-5.02%)
At close: May 17, 2024, 4:00 PM
4.780
+0.050 (1.06%)
After-hours: May 17, 2024, 7:01 PM EDT
Ventyx Biosciences Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Ventyx Biosciences stock have an average target of 20.5, with a low estimate of 2.00 and a high estimate of 62. The average target predicts an increase of 333.40% from the current stock price of 4.73.
Analyst Consensus: Buy
* Price targets were last updated on Mar 13, 2024.
Analyst Ratings
The average analyst rating for VTYX stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 0 | 1 | 1 | 1 |
| Buy | 3 | 3 | 2 | 4 | 4 | 4 |
| Hold | 5 | 5 | 6 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 8 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $16 → $15 | Strong Buy | Maintains | $16 → $15 | +217.12% | Mar 13, 2024 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $12 | Hold → Buy | Upgrades | $12 | +153.70% | Mar 12, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $7 → $16 | Hold → Buy | Upgrades | $7 → $16 | +238.27% | Mar 12, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $20 → $16 | Strong Buy | Maintains | $20 → $16 | +238.27% | Mar 11, 2024 |
| Oppenheimer | Oppenheimer | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 21, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.72
from -3.30
EPS Next Year
-2.64
from -2.72
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 350.2M | 707.0M | 1.4B |
| Avg | n/a | n/a | 56.7M | 148.5M | 325.0M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 1,147.1% | 831.2% |
| Avg | - | - | - | 162.0% | 118.8% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.65 | -1.31 | 0.05 | 3.97 | 10.43 |
| Avg | -2.72 | -2.64 | -1.68 | -0.85 | 0.82 |
| Low | -4.10 | -4.35 | -2.58 | -3.17 | -3.09 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.